1. Comparative effectiveness of ventricular tachycardia ablation versus escalated antiarrhythmic drug therapy by location of myocardial infarction: A sub-study of the VANISH trial. (24th May 2021) Authors: Samuel, M; Rivard, L; Nault, I; Gula, L; Essebag, V; Parkash, R; Sterns, LD; Khairy, P; Sapp, JL Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reduction in shock burden with catheter ablation versus escalated antiarrhythmic drug therapy: Insights from the VANISH trial. (19th May 2022) Authors: Samuel, M; Healey, J; Nault, I; Sterns, LD; Essebag, V; Gray, C; Hruczkowski, T; Gardner, M; Parkash, R; Sapp, JL Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗